Ruth, I; Hoppe-Lotichius, M; Foltys, D et al.
Liver Transplant in Recipients over 65 Years of Age: A Justified Trend?LIVER TRANSPLANTATION. Bd. 16. H. 6. 2010 S. S251-S251
Barreiros, AP; Post, F; Hoppe-Lotichius, M et al.
Liver Transplantation and Combined Liver-Heart Transplantation in Patients with Familial Amyloid Polyneuropathy: A Single-Center ExperienceLIVER TRANSPLANTATION. Bd. 16. H. 3. 2010 S. 314-323
Pannicke, N; Dziadek, L; Sterneck, M et al.
LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS: AN ANALYSIS OF MEDICAL AND SURGICAL RISK FACTORSTRANSPLANT INTERNATIONAL. Bd. 23. 2010 S. 26-26
Zimmermann, T; Hoppe-Lotichius, M; Tripkovic, V et al.
Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for Post-Transplant Lymphoproliferative Disease (PTLD)EUROPEAN JOURNAL OF INTERNAL MEDICINE. Bd. 21. H. 3. 2010 S. 208-215
Teufel, A; Maass, T; Strand, S et al.
Liver-specific Ldb1 deletion results in enhanced liver cancer developmentJOURNAL OF HEPATOLOGY. Bd. 53. H. 6. 2010 S. 1078-1084
Hockel, M; Kahn, T; Einenkel, J et al.
Local spread of cervical cancer revisited: A clinical and pathological pattern analysisGYNECOLOGIC ONCOLOGY. Bd. 117. H. 3. 2010 S. 401-408
Abegunewardene, N; Schmidt, KH; Vosseler, M et al.
Local Transient Myocardial Liposomal Gene Transfer of Inducible Nitric Oxide Synthase Does Not Aggravate Myocardial Function and Fibrosis and Leads to Moderate Neovascularization in Chronic Myocardial Ischemia in PigsMICROCIRCULATION. Bd. 17. H. 1. 2010 S. 69-78
Pedrosa, DJ; Cleppien, D; Karpi, A et al.
Lokale autologe Transplantation endothelialer Progenitorzellen (EPC-Tx) in chronisch-ischämisches Myokard steigert Kontraktilität in nicht-ischämischen Arealen: Verhinderung des negativen RemodelingFortschr Roentgenstr. Bd. 182. 2010 S. S303
Kasaj, A; Willershausen, B
Lokale Parodontitistherapie durch gezielte Chlorhexidinanwendung (PerioChip®)Parodontologie. Bd. 21. H. 3. 2010 S. 215-221
Braunlin, E; Rosenfeld, H; Kampmann, C et al.
LONG TERM CARDIAC EFFECTS OF NAGLAZYME (R) (GALSULFASE) THERAPY (nrx) IN MPS VI PATIENTSJOURNAL OF INHERITED METABOLIC DISEASE. Bd. 33. 2010 S. S154-S154